NOVEL COMPOUNDS COMPRISING A NEW CLASS OF TRANSTHYRETIN LIGANDS FOR TREATMENT OF COMMON AGE-RELATED COMORBIDITIES

The present invention provides a pharmaceutical composition comprising the compound of any the present invention and a pharmaceutically acceptable carrier. The present invention provides a method for stabilizing TTR tetramers in a mammal comprising administering to the mammal an amount of a compound of the present invention or a composition of the present invention effective to stabilize TTR tetramers..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 20. Dez. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

PETRUKHIN KONSTANTIN [VerfasserIn]
RACZ BOGLARKA [VerfasserIn]
VARADI ANDRAS [VerfasserIn]
CIOFFI CHRISTOPHER L [VerfasserIn]
MUTHURAMAN PARTHASARATHY [VerfasserIn]
RAJA ARUN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-12-20, Last update posted on www.tib.eu: 2024-01-17, Last updated: 2024-01-26

Patentnummer:

EP4291191

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018869211